InCarda Therapeutics InCarda Therapeutics is a biopharmaceutical company that develops cardiovascular treatments. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ![]() Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
| Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. | ||
Founding Date | Founding Date 2009 | Founding Date 1997 | Founding Date N/A | Founding Date 2016 | Founding Date 1998 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Newark, US HQ Melbourne, AU | Locations Ahmedabad, IN HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Dublin, IE HQ | Locations San Francisco, US HQ Uniondale, US |
Employees | Employees 157% increase | Employees 3052% increase | Employees 29723% increase | Employees 3310% increase | Employees 205% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 500 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.3m (FY, 2022) |
Net income | Net income N/A | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income N/A | Net income ($38.8m) (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round $ 42m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (almost 7 years ago) | Latest funding round $ 15.4m (almost 8 years ago) |
Total funding raised | Total funding raised $ 47.6m | Total funding raised N/A | Total funding raised $ 267.3m | Total funding raised $ 162.3m | Total funding raised $ 19.7m |

Amanta Healthcare is a company that manufactures sterile liquid parenterals.
View company
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
View companyAngion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View company